Curcumin and Piperine
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
What's the purpose of the trial?
To explore the use of curcumin and piperine supplementation at a dose of 4 gram/5mg twice a day in early stage prostate cancer patient undergoing active surveillance or patients on observation for MGUS/ low-risk smoldering myeloma.
Accepting patients
Participating Centers
There is one center participating in this trial. Enter a location below to view the distance.
Experimental Treatments
Learn more about the experimental treatments being evaluated in this clinical trial.
- Curcumin is a bright yellow chemical produced by plants of the Curcuma longa species. Ongoing clinical trials are exploring the anticancer effects of curcumin.
- Piperine is an alkaloid present in black pepper, one of the most widely used spices, in long pepper, and other Piper species fruits belonging to the family of Piperaceae. Ongoing clinical trials are exploring the anticancer effects of Piperine.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.